COMMUNIQUÉS West-GlobeNewswire

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026
19/10/2026
SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
19/10/2026
Clover Health plans are named Best Medicare Advantage Plans in New Jersey, Georgia, and South Carolina, scoring highest in all three states for Best for Care Continuity. WILMINGTON, Del., Oct. 19, 2026 (GLOBE NEWSWIRE [...]
CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer
19/10/2026
Dr. Jacob Lalezari to remain with Company in scientific innovation and discovery role VANCOUVER, Washington, Oct. 19, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage [...]
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
19/10/2026
Transaction Expected to Add More Than $10 Million to Stockholders' Equity as Vivos Forms Strategic Alliances Offering Potential New Revenue and Profit Opportunities LITTLETON, Colo., Oct. 19, 2026 (GLOBE NEWSWIRE) -- [...]
Conavi Medical Announces New Grants of Stock Options
19/10/2026
TORONTO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing and marketing [...]
Groundbreaking therapy for advanced heart failure: Repairon Strengthens Executive Leadership with Appointment of Detlef Schumann, Ph.D. as Chief Operating Officer
19/10/2026
Biotech executive brings global leadership and operations experience to speed clinical development, expand operations, and carry out strategic growth plans. GÖTTINGEN, Germany and PROVIDENCE, R.I., Oct. 19, 2026 (GLOBE [...]
Une thérapie révolutionnaire pour l’insuffisance cardiaque avancée : Repairon renforce son équipe de direction avec la nomination de Detlef Schumann, Ph.D., au poste de directeur des opérations
19/10/2026
Ce dirigeant du secteur biotechnologique apporte une expérience internationale en matière de direction et d’opérations, visant à accélérer le développement clinique, à étendre les activités et à mettre en œuvre des [...]
Xealth to Lead Session on AI Applications and Digital Technologies Reshaping Healthcare at IHF World Congress
19/10/2026
SEOUL, South Korea, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and deployment, today announced that Xealth CEO Mike McSherry will chair a session on innovative applications of [...]
Maxim Hair Restoration, a Leading FUE Hair Transplant Provider, Named a 2026 Best of America Small Business Awards Winner
19/10/2026
BASA Awards® recognizes Maxim in the Health Care & Medical Center category New York City, NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Maxim Hair Restoration has been named among the winners of the 2026 Best of [...]
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
19/10/2026
Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “ [...]
Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
19/10/2026
Approval based on AZUR-1 data showing significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported among responders after median follow up of [...]
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
19/10/2026
Premier sponsorship of the HERmedicine and OncoMenopause Consortium ® program underscores Daré Bioscience's commitment to addressing unmet women’s health needs, including for women affected by breast cancer The program [...]
Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy
19/10/2026
The partnership connects Beacon's AI-driven neurotechnology with the patient-led advocacy community, expanding access to diagnosis and bringing patient voices directly into clinical research BOSTON, Oct. 19, 2026 (GLOBE [...]
ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates
19/10/2026
World-Renowned Sleep Medicine Leaders Join ProSomnus Medical Advisory Board, RPMO₂ Enhancements, Published FLOSAT Study Results, and Scientific Contributions at CHEST 2026 SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE [...]
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
19/10/2026
ALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice President of Sales and [...]
VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity
19/10/2026
— Landmark European approval will grant young patients and families an evidence-based therapy alongside lifestyle interventions AMSTERDAM, Oct. 19, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a [...]
Final Safety, Pharmacokinetic and Pharmacodynamic Data from COL-5671 Phase 1 Clinical Study Presented at UEGW
19/10/2026
COL-5671, a highly selective oral SIK3 inhibitor, demonstrated a favorable safety and pharmacokinetic (PK) profile Pharmacodynamic (PD) data indicate potent TNFα suppression at low doses , with even greater IL-23 [...]
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
19/10/2026
TORONTO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to [...]
XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer
19/10/2026
Investigator-sponsored study funded by the French National Cancer Institute (INCa) meets pre-specified primary efficacy success criterion with 61.3% 12-month overall survival. Exploratory Subgroup analysis reveals [...]

Pages